Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Titel:
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Auteur:
Lordick, F. Mauer, M.E. Stocker, G. Cella, C.A. Ben-Aharon, I. Piessen, G. Wyrwicz, L. Al-Haidari, G. Fleitas-Kanonnikoff, T. Boige, V. Lordick Obermannová, R. Martens, U.M. Gomez-Martin, C. Thuss-Patience, P. Arrazubi, V. Avallone, A. Shiu, K.K. Artru, P. Brenner, B. Buges Sanchez, C. Chau, I. Lorenzen, S. Daum, S. Sinn, M. Merelli, B. van Grieken, N.C.T. Nilsson, M. Collienne, M. Giraut, A. Smyth, E.